This study aimed to measure the NGAL levels in BM samples of patients who underwent BM examination for the diagnosis of hematological malignancies and evaluate whether BM NGAL has a significant association with hematological parameters including neutrophil count. The gene discussed is LCN2; the disease is hematologic disorder.